Definition of Healthy Ranges for Alanine Aminotransferase Levels: A 2021 Update

被引:51
作者
Valenti, Luca [1 ,2 ]
Pelusi, Serena [1 ,2 ]
Bianco, Cristiana [2 ,3 ]
Ceriotti, Ferruccio [4 ]
Berzuini, Alessandra [2 ]
Prat, Laura Iogna [5 ,6 ]
Trotti, Roberta [2 ]
Malvestiti, Francesco [1 ,2 ]
D'Ambrosio, Roberta [7 ]
Lampertico, Pietro [7 ,8 ]
Colli, Agostino [2 ]
Colombo, Massimo [9 ]
Tsochatzis, Emmanuel A. [5 ,6 ]
Fraquelli, Mirella [10 ]
Prati, Daniele [2 ]
机构
[1] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Transfus Med & Haematol, Milan, Italy
[3] Udine Hosp, Dept Med, Udine, Italy
[4] Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Clin Lab, Milan, Italy
[5] Royal Free Hosp, UCL Inst Liver & Digest Hlth, London, England
[6] UCL, London, England
[7] Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Div Gastroenterol & Hepatol, Milan, Italy
[8] Univ Milan, CRC AM & A Migliavacca Ctr Liver Dis, Dept Pathophysiol & Transplantat, Milan, Italy
[9] IRCCS San Raffaele Hosp, Liver Ctr, Milan, Italy
[10] Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Dept Gastroenterol & Endoscopy, Milan, Italy
基金
欧盟地平线“2020”;
关键词
NONALCOHOLIC FATTY LIVER; INSULIN-RESISTANCE; HEPATIC STEATOSIS; UNITED-STATES; UPPER LIMITS; DISEASE; PREVALENCE; ALT; STEATOHEPATITIS; ASSOCIATION;
D O I
10.1002/hep4.1794
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The changing epidemiology of liver disease, and modifications in the recommended analytical methodology call for a re-evaluation of the upper reference limits (URLs) of alanine aminotransferase (ALT) levels. Using the same approach consolidated 20 years ago to define the healthy population, we defined the URL for the newly recommended International Federation of Clinical Chemistry (IFCC) standardized test. In a cross-sectional study, we examined 21,296 apparently healthy blood donors (age 18-65 years) and calculated the sex-specific URL by the 95th percentile in individuals without risk factors for liver disease. These were tested for the ability to predict liver damage in a subset of 745 participants with dysmetabolism, in an independent cohort of 977 unselected donors, and in 899 patients with chronic liver disease. ALT levels were measured by the IFCC test. Male sex, body mass index, glucose, lipids, ferritin, hypertension, and younger age were independent ALT predictors (P < 0.001). Updated URLs were identified at 42/30 U/L in males/females, approximately 30% lower than those currently recommended by the IFCC. Due to improved sensitivity, they conferred the ability to detect steatosis and significant fibrosis in individuals with dysmetabolism (odds ratio [OR] = 2.31, range 1.40-3.80, P = 0.001; and OR = 3.35, range 1.19-9.42, P = 0.021; respectively), although with a limited accuracy, and significant fibrosis in unselected donors (OR = 2.32, 1.02-5.31, P = 0.045). Updated URLs had a moderate to high accuracy to discriminate liver conditions (area under the receiver operating characteristic curve = 0.81, range 0.78-0.91). Conclusion: Updated URLs by the IFCC method were lower than those calculated in initial studies, but higher than those in use with the recommended old, nonstandardized method, and were able to better predict liver disease. The limited awareness that different techniques are still in use should be regarded as a possible source of medical errors.
引用
收藏
页码:1824 / 1832
页数:9
相关论文
共 41 条
  • [1] Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals
    Bazerbachi, Fateh
    Haffar, Samir
    Wang, Zhen
    Cabezas, Joaquin
    Teresa Arias-Loste, Maria
    Crespo, Javier
    Darwish-Murad, Sarwa
    Ikram, M. Arfan
    Olynyk, John K.
    Gan, Eng
    Petta, Salvatore
    Berzuini, Alessandra
    Prati, Daniele
    de Ledinghen, Victor
    Wong, Vincent W.
    Del Poggio, Paolo
    Chavez-Tapia, Norberto C.
    Chen, Yong-Peng
    Cheng, Pin-Nan
    Yuen, Man-Fung
    Das, Kausik
    Chowdhury, Abhijit
    Caballeria, Llorenc
    Fabrellas, Nuria
    Gines, Pere
    Kumar, Manoj
    Sarin, Shiv Kumar
    Conti, Fabio
    Andreone, Pietro
    Sirli, Roxana
    Cortez-Pinto, Helena
    Carvalhana, Sofia
    Sugihara, Takaaki
    Kim, Seung Up
    Parikh, Pathik
    Chayama, Kazuaki
    Corpechot, Christophe
    Kim, Kang Mo
    Papatheodoridis, George
    Alsebaey, Ayman
    Kamath, Patrick S.
    Murad, M. Hassan
    Watt, Kymberly D.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (01) : 54 - +
  • [2] Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
    Browning, JD
    Szczepaniak, LS
    Dobbins, R
    Nuremberg, P
    Horton, JD
    Cohen, JC
    Grundy, SM
    Hobbs, HH
    [J]. HEPATOLOGY, 2004, 40 (06) : 1387 - 1395
  • [3] Common reference intervals for aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) in serum: results from an IFCC multicenter study
    Ceriotti, Ferruccio
    Henny, Joseph
    Queralto, Josep
    Ziyu, Shen
    Ozarda, Yesim
    Chen, Baorong
    Boyd, James C.
    Panteghini, Mauro
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2010, 48 (11) : 1593 - 1601
  • [4] Deciding on Interferon-Free Treatment for Chronic Hepatitis C: Updating Liver Stiffness Cut-Off Values to Maximize Benefit
    Colli, Agostino
    Fraquelli, Mirella
    Prati, Daniele
    Riva, Alessia
    Berzuini, Alessandra
    Conte, Dario
    Aghemo, Alessio
    Colombo, Massimo
    Casazza, Giovanni
    [J]. PLOS ONE, 2016, 11 (10):
  • [5] Intelligent liver function testing (iLFT): A trial of automated diagnosis and staging of liver disease in primary care
    Dillon, John F.
    Miller, Michael H.
    Robinson, Emma M.
    Hapca, Adrian
    Rezaeihemami, Mohsen
    Weatherburn, Christopher
    McIntyre, Paul G.
    Bartlett, Bill
    Donnan, Peter T.
    Boyd, Kathleen A.
    Dow, Ellie
    [J]. JOURNAL OF HEPATOLOGY, 2019, 71 (04) : 699 - 706
  • [6] Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target
    Dongiovanni, Paola
    Fracanzani, Anna Ludovica
    Fargion, Silvia
    Valenti, Luca
    [J]. JOURNAL OF HEPATOLOGY, 2011, 55 (04) : 920 - 932
  • [7] EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
    European Association for the Study of the Liver
    [J]. DIABETOLOGIA, 2016, 59 (06) : 1121 - 1140
  • [8] Correlation between serum alanine aminotransferase activity and age: An inverted U curve pattern
    Elinav, E
    Ben-Dov, IZ
    Ackerman, E
    Kiderman, A
    Glikberg, F
    Shapira, Y
    Ackerman, Z
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (10) : 2201 - 2204
  • [9] Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030
    Estes, Chris
    Anstee, Quentin M.
    Teresa Arias-Loste, Maria
    Bantel, Heike
    Bellentani, Stefano
    Caballeria, Joan
    Colombo, Massimo
    Craxi, Antonio
    Crespo, Javier
    Day, Christopher P.
    Eguchi, Yuichiro
    Geier, Andreas
    Kondili, Loreta A.
    Kroy, Daniela C.
    Lazarus, Jeffrey V.
    Loomba, Rohit
    Manns, Michael P.
    Marchesini, Giulio
    Nakajima, Atsushi
    Negro, Francesco
    Petta, Salvatore
    Ratziu, Vlad
    Romero-Gomez, Manuel
    Sanyal, Arun
    Schattenberg, Joern M.
    Tacke, Frank
    Tanaka, Junko
    Trautwein, Christian
    Wei, Lai
    Zeuzem, Stefan
    Razavi, Homie
    [J]. JOURNAL OF HEPATOLOGY, 2018, 69 (04) : 896 - 904
  • [10] Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes
    Fracanzani, Anna Ludovica
    Valenti, Luca
    Bugianesi, Elisabetta
    Andreoletti, Marco
    Colli, Agostino
    Vanni, Ester
    Bertelli, Cristina
    Fatta, Erika
    Bignamini, Daniela
    Marchesini, Giulio
    Fargion, Silvia
    [J]. HEPATOLOGY, 2008, 48 (03) : 792 - 798